WESTFORD, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference.
Chief Financial Officer Timothy Baker will discuss Cynosure's business outlook, growth strategy and recent financial results in a presentation beginning at 2:10 p.m. ET Wednesday, October 3. The conference will be held at the Grand Hyatt New York Hotel. Investors interested in listening to the live webcast of this presentation should log on to the "Investor Relations" section of Cynosure's website, http://www.cynosure.com, and click on the link labeled "Events." The presentation will be archived on the company's website.
About Leerink Swann & Company
Leerink Swann is a healthcare-focused investment banking firm that
provides equity research, corporate finance, asset management, and
strategic advisory services for institutional, life sciences, and high net
worth clients. For the past six years, Institutional Investor has named
Leerink Swann "Best of the Boutiques" in Healthcare. Through its MEDACorp
division, Leerink Swann provides biomedical-consulting services to the
institutional investment community. With an internal team of experts and a
dedicated external network of academic and community-based healthcare
professionals, MEDACorp assesses the viability of cutting-edge medical
technologies, thus giving decision makers the information they need to
perform. Leerink Swann is a member NASD/SIPC. For more information, visit
|SOURCE Cynosure, Inc.|
Copyright©2007 PR Newswire.
All rights reserved